improsan has been researched along with Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altman, SJ; Fletcher, WS; Madden, RE; Metter, GE; Multhauf, PM; Nealon, TF; Ramirez, G; Strawitz, JG; Weiss, AJ | 1 |
1 trial(s) available for improsan and Neoplasms
| Article | Year |
|---|---|
Yoshi 864 (1-propanol, 3,3'-iminodi-, dimethanesulfonate [ester], hydrochloride): a phase II study in solid tumors.
Topics: Alkylating Agents; Blood Cell Count; Blood Platelets; Clinical Trials as Topic; Drug Evaluation; Hematocrit; Hemoglobins; Humans; Leukocyte Count; Mesylates; Neoplasms; Propylamines; Time Factors | 1978 |